LIC MF Healthcare Fund-Regular Plan-IDCW
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 22-02-2019
AUM:
₹ 99.36 Cr
Expense Ratio
2.67%
Benchmark
BSE Healthcare TRI
ISIN
INF397L01LD9
Minimum Investment
5000.0
Minimum Topup
500.0
Minimum SIP Amount
200
Fund Manager
Sudhanshu Asthana, Dhaval Sangoi
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| LIC MF Healthcare Fund-Regular Plan-IDCW | 7.23 | 20.19 | 10.92 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
32.0373
Last change
0.82 (2.5551%)
Fund Size (AUM)
₹ 99.36 Cr
Performance
16.42% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Manager
Sudhanshu Asthana, Dhaval Sangoi
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 9.59 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 9.07 |
| NEULAND LABORATORIES LIMITED EQ | 6.14 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 6.04 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.75 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 5.23 |
| NAVIN FLUORINE INTERNATIONAL LTD EQ NEW FV RS. 2/- | 4.98 |
| ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/- | 4.97 |
| ASTER DM HEALTHCARE LIMITED EQ | 4.61 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.77 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 92.55 |
| Chemicals | 4.98 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| LIC MF Healthcare Fund Reg IDCW | 10.92 |